Production of Monacolin K in Monascus pilosus: Comparison between Industrial Strains and Analysis of Its Gene

Weihua Dai1,2, Yanchun Shao1,2, Fusheng Chen1,2

  • 1Hubei International Scientific and Technological Cooperation Base of Traditional Fermented Foods, Huazhong Agricultural University, Wuhan 430070, China.

Microorganisms
|April 30, 2021
PubMed

Insights

This study investigates monacolin K (MK) production by four Monascus pilosus strains, revealing significant yield differences in solid and liquid cultures. Genome analysis shows variations in MK biosynthetic gene clusters, offering insights into MK synthesis mechanisms.

Area of Science:

  • Microbiology and Biotechnology
  • Metabolic Engineering
  • Genomics

Background:

  • Monascus pilosus is a key producer of monacolin K (MK), a cholesterol-lowering compound also known as lovastatin (LOV).
  • The precise mechanisms governing MK production by M. pilosus remain incompletely understood.
  • Comparative analysis of MK biosynthesis across different Monascus strains is limited.

Purpose of the Study:

  • To confirm four commercial MK product isolates as Monascus pilosus strains.
  • To compare the MK production capabilities of these strains under solid-state and liquid-state fermentation.
  • To analyze the genomes and MK biosynthetic gene clusters (BGCs) of these strains.

Main Methods:

  • Isolation and identification of Monascus strains from commercial products.
  • Solid-state and liquid-state fermentation for MK production.
  • Genome sequencing and bioinformatic analysis of MK BGCs.
  • Quantitative analysis of MK yields and content.

Main Results:

  • Four strains (MS-1, YDJ-1, YDJ-2, K104061) were confirmed as M. pilosus, exhibiting varied MK yields in solid-state (0.76–6.13 mg/g) and liquid-state (0.30–1.8 mg/g) cultures.
  • Genome analysis revealed approximately 26 Mb genome size with 7000–8000 coding genes and one MK BGC per strain.
  • MK BGCs varied in gene number (9–11 genes), with MS-1 showing the highest MK yield.

Conclusions:

  • Significant variations in MK production exist among M. pilosus strains, influenced by fermentation conditions.
  • The MK BGCs in M. pilosus are less complex than those for lovastatin synthesis in other organisms, suggesting distinct evolutionary pathways.
  • This study provides a foundational understanding for exploring MK biosynthesis mechanisms and comparative analysis with lovastatin synthesis.

Related Concept Videos

Bioreactor Controls-III01:22

Bioreactor Controls-III

Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Alcohol01:27

Production of Alcohol

Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...